We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-20.00 | -4.30% | 445.00 | 440.00 | 450.00 | 465.00 | 445.00 | 465.00 | 80,181 | 16:04:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 36.01M | 4.46M | 0.0941 | 47.29 | 210.93M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/6/2017 14:54 | An economic analysis of the benefits of sterilizing medical instruments in low-temperature systems instead of steam Victoria McCreanor, LLB, MSc , Nicholas Graves, PhD Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia ABSTRACT Highlights •Low-temperatur •Using low-temperature sterilization for steam-sterilizable endoscopes will save costs. •Increased sterilization costs are outweighed by savings realized because of fewer repairs. Background Hydrogen peroxide–based Methods This analysis examines the economic effects of using low-temperature sterilization systems to reprocess rigid and semi-rigid endoscopes, which are sensitive to heat and moisture, but still able to be sterilized using steam. It examines the changes to costs and frequency of repairs expected over 10 years, resulting from a choice to sterilize these instruments in a low-temperature system instead of steam. Results Overall, the results showed that increased sterilization costs are outweighed by the savings associated with less frequent repairs. Over a 10-year period, in large health care facilities, the probability of achieving an internal rate of return of at least 6% is 0.81. Conclusions Our model shows it is likely to be a good decision for large health care facilities to invest in low-temperature sterilization systems. | piedro | |
20/6/2017 18:10 | Tristel Global @TristelGlobal We are exhibiting at #BSG2017 with Tristel Rinse Assure (RA): Rinse Water Management for AERs. @BritSocGastro #waterquality #RAisthenewRO 🙌 - feeling giddy !!! | piedro | |
13/6/2017 18:43 | There's usually a reason why the .1% survive, they are mutating and developing immunity. They then become the majority strain over time, helped by the competition being killed off. One other factor I think is the fact that Byotrol have EPA approval for surface cleaning, they don't have FDA approval for use on internal examination equipment such as endoscopes. | melton john | |
13/6/2017 13:55 | Well spotted. One to quiz the company about at the forthcoming Summer shindig. I vaguely remember someone at Tristel commenting previously in relation to a household disinfectant (Domestos) when the potential of Puffin was being discussed that a 99.9% kill rate is not that wonderful, as the remaining 0.1% is more than enough to finish you off. | james188 | |
13/6/2017 09:22 | Interesting ... RNS Number : 8664H Byotrol PLC 13 June 2017 APPROVAL RECEIVED FROM U.S. ENVIRONMENTAL PROTECTION AGENCY ("EPA") FOR LONG-LASTING ANTI-MICROBIAL PRODUCT Byotrol plc, the specialist anti-microbial technology company, is pleased to announce that the US EPA has formally approved Byotrol's proprietary 24-hour germ-kill surface sanitizer for sale in the US (EPA Reg. Number 83614-1). The formulation has been under development at Byotrol for over seven years and the Directors believe offers unique performance characteristics to US consumers and businesses. To US consumers our products will be able to claim high performance cleaning and viricidal action, plus long-lasting benefits such as: - 24-hour surface protection against bacteria - Scientifically proven to kill >99.9% of bacteria for 24 hours - 7 day mold and mildew prevention - Eliminates >99.9% of viruses The Directors are not aware of any other cleaning or sanitizing products that can make such claims for US consumers; we believe this approval gives Byotrol a unique opportunity in the substantial US market. ... ... ... ... | piedro | |
12/6/2017 09:47 | Will the BPR affect your ability to continue to disinfect your life science cleanroom ? Cleanroom operators rely heavily on biocides to ensure surfaces and equipment are disinfected effectively between operations. European GMP sets stringent viable microbial limits for pharmaceutical and medical device manufacturers and most manufacturers will use one or more validated disinfectants, including 70% alcohol solutions in their facilities. But since the EU introduced the Biocidal Products Regulation (EU) No 528/2012, this new system of governance has seen some traditional biocidal products withdrawn from the market. This year the cleanroom sector will begin to feel the full impact of the EU Biocide regulation, as many of the transitional periods introduced by the BPR will come to an end, and further cleanroom disinfectants will be withdrawn from the market. Biocidal product manufacturers and suppliers up and down the supply chain – whether non-EU manufacturers exporting to the EU, EU importers or manufacturers – have been proactively preparing the various procedures that will allow them to continue operating on the EU biocides market. At the Cleanroom Technology Conference 2017, Alison Livsey, Product Manager with manufacturer of contamination control products for mission-critical cleaning in manufacturing environments, Contec Inc, will discuss the effect of the BPR on the cleanroom sector so far, outlining what cleanroom companies can do to ensure they are compliant and their disinfectant supply is not compromised now or in the future? Livsey will also discuss the topical question of what impact Brexit could have on applying the BPR for UK cleanroom users/disinfectant manufacturers. The Cleanroom Technology Conference 2017 is designed to highlight best practice and regulations affecting both cleanroom design and cleanroom operation across various sectors for those working in controlled environments and cleanrooms. - Tristel not on the list of exhibitors | piedro | |
07/6/2017 16:09 | Zimtrader, you're right the link now goes to the email. Good to see someone follows the thread, but they should have more care with the photos - too much floor and ceiling IMHO :-) | piedro | |
07/6/2017 16:02 | Ecomed @EcomedServices EcomedSF2H à Nice: visitez notre stand! @LaSF2H @TristelGlobal #infectionprevention #Tristel | piedro | |
07/6/2017 15:32 | Piedro, may have been a HTML minor coding error which appears to have been corrected. I just checked and the link now goes says "mailto:tristel@walb | zimbtrader | |
07/6/2017 08:10 | Melton John, I'm not sure I get your point Piedro. Nothing happened when I clicked the email link. I only use googlemail so I would copy and paste tristel@walbrookpr.c That's curious, the link says : but when I click it goes to : | piedro | |
06/6/2017 18:48 | Personally I was looking to rebuy on the break and it failed miserably so off the watch list for the time being | davr0s | |
06/6/2017 15:24 | Couldn't agree more, Melton. I've topped up at 189 on the basis I am happy to take such a risk with polling day looming. Be interested to hear any other views from other holders. | zimbtrader | |
06/6/2017 15:09 | My point mate, was the main UK customer is the NHS, so if Corbyn wins they'll throw more money at it 'cause that's what they do. Tristel isn't a discretionary buy for the NHS. Agree for other reasons Corbyn would be a disaster. I found a Marxist website that would love him to win as a stalking horse with his gentle everybody play nicely front fooling the naïve first time voters while the shock troops move into position. Cue The Who- Won't get fooled again. So just a tree shake imho, I could sell 8000 for 1.836 but buying soon puts the price up if you want volume. | melton john | |
06/6/2017 14:26 | Mmmm. Salvation poll released 4 hours ago suggests the gap has narrowed to 1 point but FTSE indices don't appear to have suffered adversely which makes TSTL an exception in terms of price drops. I hope this is no more than market makers shaking the tree to trigger a few stop losses and pick up cheap shares rather than something more ominous... And if Corbyn won, Melton, we'd have far, far more to fear than a stock market crash. Especially if there was an unholy alliance with the SNP. Shudder! | zimbtrader | |
06/6/2017 14:09 | If you want to hedge against a Corbyn win, give away your shares now. As far as I can see we are holding a win/win share whatever the result and I won't be selling. | melton john | |
06/6/2017 14:04 | I'm not sure I get your point Piedro. Nothing happened when I clicked the email link. I only use googlemail so I would copy and paste tristel@walbrookpr.c Do tell what your unpleasant surprise was. | melton john | |
06/6/2017 13:47 | Anyone got an clues regards the sudden rather steep drop today from about 11:00 this morning? Volume doesn't seem unusual, no big trades (so far) and no news as far as I can see... | zimbtrader | |
06/6/2017 08:16 | Browsing through the Tristel website I got an unpleasant surprise. Investor Centre > Investor News > gives ... Investor News Please click on any of the links to see investor news and letters per year. If you can't find what you're looking for, please contact Investor Relations. To sign up to receive Investor News as it is released please email tristel@walbrookpr.c Try the 'sign up' link | piedro | |
05/6/2017 10:37 | Tristel Global @TristelGlobal Last day to visit the team on Stand 6 at # euroanaesthesia2017 and pick up your free sample of Tristel Protect! #seeyouthere #disinfection | piedro | |
24/5/2017 07:08 | Openday on 19 July - trading update also to be released. | glaws2 | |
22/5/2017 15:57 | The 2017 Sterile Processing State of the Industry Report - will need to register to read | piedro |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions